- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …Sponsor and Lead .Manages an integrated project and resource plan for Strategic Initiatives Team in partnership with the Project leads and functional ... & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients...of multiple myeloma.Legend Biotech is seeking a Quality Systems Lead as part of the Quality team based in… more
- Merck & Co. (South San Francisco, CA)
- …high quality characterization data to advance therapeutic programs from de novo discovery into lead candidate selection, this individual will be responsible ... drive our core mission. In this role, you will: Lead a team of scientists in SSF Discovery...talent development, and pipeline advancementLead and participate in cross-functional discovery project teams in partnership with therapeutic… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Eisai, Inc (Nutley, NJ)
- …Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer's disease. As we ... of that plan.Champion CQA's mission of 'Quality as enabler of business'; lead global initiatives for continuous improvement.Trend and leverage internal audit and… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pathology, to support design and implementation of translational pathology plans.- Lead development of the translational pathology strategic direction and ... investigations and as a point of contact for developing and managing external partnerships in support of translational science and CDx programs. They will provide… more
- Eisai, Inc (Sacramento, CA)
- …Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer's disease. As we ... needs, issues and priorities as they relate to Eisai's strategic business plan and is able to 'connect the...state and Eisai's product(s) to ensure awareness and understanding. Lead assigned professional congresses in accordance with MSL plan… more
- Eisai, Inc (Nutley, NJ)
- …Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer's disease. As we ... Associate Director, Medical Education - Oncology, is responsible for the strategic planning and execution of relevant medical communications deliverables aligned… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …& Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and ... the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend Biotech… more
- Eisai, Inc (Atlanta, GA)
- …collaboration of prescriber-level selling efforts across a multiple indication team. Lead account responsibility for assigned strategic accounts including ... Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer's disease. As we… more
